H1N1 flu :: Pandemic swine flu – H1N1 Influenza

Novel H1N1 (referred to as “swine flu” early on) is a new influenza virus causing illness in people. This new virus was first detected in people in the United States in April 2009. Other countries, including Mexico and Canada, have reported people sick with this new virus. This virus is spreading from person-to-person, probably in much the same way that regular seasonal influenza viruses spread.

Health :: First aid for family health and homoeopathy

Homeopathy is a safe and effective system of medicine, which can be used with confidence for treating the whole family. It is simple to use, has no taste or smell and has no side effects. Every home should have a simple, readily accessible first aid box containing sticking plasters, cotton wool and bandages.

Antioxidant :: Antioxidants could provide all-purpose radiation protection

Two common dietary molecules found in legumes and bran could protect DNA from the harmful effects of radiation, researchers from the University of Maryland report. Inositol and inositol hexaphosphate (IP6) protected both human skin cells and a skin cancer-prone mouse from exposure to ultraviolet B (UVB) radiation, the damaging radiation found in sunlight, the team reported today at the American Association for Cancer Research Centennial Conference on Translational Cancer Medicine.

Thyroid :: FDA acts to ensure thyroid drugs don’t lose potency before expiration date

The U.S. Food and Drug Administration is tightening the potency specifications for levothyroxine sodium, used to treat underactive thyroid glands and other thyroid conditions, to ensure the drug retains its potency over its entire shelf life. This action is being taken in response to concerns that the potency of the drug may deteriorate prior to its expiration date.

Blood :: Possible safer target for anti-clotting drugs found

Researchers at the University of Illinois at Chicago College of Medicine have identified a new molecular target in the process of blood clot formation, which seems to reduce clotting without excessive bleeding, the common side-effect of anti-clotting agents.

Cancer :: Scientists follow familiar TRAIL to new cancer therapy

A new study identifies a combination therapy that may sensitize human cancer cells to a promising treatment currently being used in clinical trials. The research, published in the July issue of the journal Cancer Cell, published by Cell Press, provides a pharmacological method for enhancing the potency and effectiveness of a tumor necrosis factor death receptor ligand against a variety of human cancers.

Do NOT follow this link or you will be banned from the site!